Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy

Completed

Conditions studied: Breast Cancer

In brief

RATIONALE: Gathering information about cognitive function over time in postmenopausal women with breast cancer may help doctors learn about the long-term effects of aromatase inhibitor therapy and plan the best treatment. PURPOSE: This clinical trial is studying cognitive function in older postmenopausal women with stage I, stage II, or stage III breast cancer receiving hormone therapy and in healthy volunteers.

Key facts

Study ID

NCT00681928

Run by

City of Hope Medical Center

People needed

72

Starts

2007-10-01

Expected to finish

2011-01-01

Last updated by the study team

2011-12-02

Who can join

Age: 65 and older. Sex: female. Healthy volunteers: accepted.

Where it is running

• City of Hope Comprehensive Cancer Center — Duarte, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.